AbbVie
ABBV
#57
Rank
$190.44 B
Marketcap
🇺🇸 USA
Country
$107.91
Share price
0.95%
Change (1 day)
31.77%
Change (1 year)
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: $190.44 B
As of April 2021 AbbVie has a market cap of $190.44 B. This makes AbbVie the world's 57th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of AbbVie from 2012 to 2021
| Year | Market cap | Change |
|---|---|---|
| 2021 | $189.78 B | 0.33% |
| 2020 | $189.17 B | 44.47% |
| 2019 | $130.94 B | -3.95% |
| 2018 | $136.33 B | -11.7% |
| 2017 | $154.39 B | 51.71% |
| 2016 | $101.76 B | 6.7% |
| 2015 | $95.37 B | -8.42% |
| 2014 | $104.14 B | 24.23% |
| 2013 | $83.82 B | 55.32% |
| 2012 | $53.97 B |